Winston Pharmaceuticals, Inc. Announces Positive Results of Phase II Clinical Trial of Dolorac Nasal Solution - Drugs.com MedNews
Links shared publicly online about this topic.
- 708total visits
Winston Pharmaceuticals, Inc. Announces Positive Results of Phase II Clinical Trial of Dolorac Nasal Solution - Drugs.com MedNews
Nov 22, 2010 - Winston Pharmaceuticals, Inc. ( Winston ), a specialty pharmaceutical company focused on developing and commercializing novel pain management the
View full resource at drugs.com
Tags: Pain Management, Pain, Nose, Drug, Pharma, Clinical Trial
Most Recently Shared on November 22, 2010 at 7:08 pm By:
Winston Pharmaceuticals, Inc. Announces Positive Results of Phase II Clinical Trial of Dolorac Nasal Solut... http://bit.ly/9Nik0y #drug
Positive Results Announced Of Phase II Clinical Trial Of Dolorac(R) Nasal Solution For Chronic Migraine
medicalnewstoday.com — “Winston Pharmaceuticals, Inc. (Winston), a specialty pharmaceutical company focused on developing and commercializing novel pain management therapies, announced the results of its Phase II study” View full resource at medicalnewstoday.com
Most Recently Shared on November 25, 2010 at 2:38 pm By:
Positive Results Announced Of Phase II Clinical Trial Of Dolorac(R) Nasal Solution For Chronic Migraine: Winston... http://mnt.to/f/3N96
Advertisement
